Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
FY2029 EPS Estimate for Moderna Cut by Analyst
What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Nov. 6
Pictet Asset Management Holding SA Sells 156,247 Shares of Moderna, Inc. $MRNA
Fulcrum Asset Management LLP Purchases 18,554 Shares of Moderna, Inc. $MRNA
Why Did U, MRNA, ABNB Stocks Surge To 52-Week Highs Today?
Company Merged HR and IT Departments: Key Outcomes and Impacts Explained
Alcon News | Markets Insider
Moderna (NASDAQ:MRNA) Shares Up 5.8% Following Strong Earnings
Moderna's Q3 Numbers May Have Seemed Impressive, but They Aren't Enough to Make the Stock a Buy - AOL
Is Moderna (MRNA) Priced For Too Much Sales Growth?
Moderna (MRNA) Stock Fair Value Rises After Intismeran Data And Q3 Beat
MRNA Maintained by Goldman Sachs -- Price Target Raised to $195
MRNA Reiterated by Piper Sandler -- Price Target Raised to $305
MRNA support and resistance levels to watch
Moderna Earnings: Raising Fair Value Estimate as Steadying Demand for Respiratory Vaccines Supports Strong Quarter | Morningstar
Best Healthcare Stocks To Keep An Eye On - November 9th - Stock Observer
The Goldman Sachs Group Issues Positive Forecast for Moderna (NASDAQ:MRNA) Stock Price - Daily Political
Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?
Moderna Stock Is Up 5.3% What's Changed After Profit Return - Simply Wall St News
Moderna (MRNA) Shares Rally After Q3 2026 Beat, Raising Full-Yea
Moderna's cost cuts turn a 29% revenue jump into a $162 million profit
Moderna, Inc. $MRNA Stock Holdings Lifted by Candriam S.C.A. - Zolmax
Moderna, Inc. $MRNA Stock Bought by Candriam S.C.A.
Promising Biotech Stocks To Watch Now - November 5th - Daily Political
Sumitomo Mitsui Trust Group Inc. Purchases 38,833 Shares of Moderna, Inc. $MRNA
Best Biotech Stocks Worth Watching - November 7th - Stock Observer
Moderna, Inc. $MRNA Shares Acquired by Sumitomo Mitsui Trust Group Inc. - Stock Observer
Moderna (NASDAQ:MRNA) Stock Falls 6.5% - Here's Why - Daily Political
Moderna (NASDAQ:MRNA) Stock Price Up 13.1% - Here's Why
Moderna (NASDAQ:MRNA) Posts Earnings Results, Beats Expectations By $1.48 EPS
Moderna (MRNA) Stock Climbs As Q3 Earnings Mark Return To Profit
Bernstein's Courtney Breen talks what is driving Moderna's post-earnings gains
Moderna (NASDAQ:MRNA) Shares Climb 5.3% on Earnings Beat
Moderna Inc (MRNA) Q3 2026 Earnings Call Highlights: Revenue Surges 29% as Guidance Raised and ...
Moderna Earnings: Steadying Demand for Respiratory Vaccines Supports Strong Quarter | Morningstar
Moderna's Impressive Intismeran Data in Melanoma Could Form Foundation of Oncology Portfolio | Morningstar
Moderna earnings analysis: questions answered and next catalysts
What Moderna (MRNA) Said on Its Q3 Earnings Call
Moderna Climbs 5% as Surprise Profit and Raised Outlook Beat Forecasts; Pfizer Dips, BioNTech Edges Higher
Moderna (MRNA) Stock: Rally 7.38% as $1.3B Revenue and Positive Cancer Trial Results Boost Optimism
Moderna raises its revenue outlook - but all eyes are on what happens next with its cancer vaccine | Morningstar
Moderna shares jump as earnings beat prompts higher 2026 sales outlook
Moderna Returns To Q3 Profit; Raises FY26 Outlook On Vaccine Sales And Pipeline Progress
Dow Jones Top Company Headlines at 9 AM ET: Tesla's Polarizing Cybertruck to Wind Down Production Amid Slow Sales | Moderna ... | Morningstar
Moderna raises its revenue outlook - but all eyes are on what happens next with its experimental cancer vaccine | Morningstar
Health Canada approves Moderna's combined COVID, flu shot for some
Moderna Turns To Q3 Profit, Revenue Rises 29%; Raises Annual Revenue Growth Outlook
5 Things Investors Need to Know About Friday's Markets
Moderna Stock Soars After $162 Million Profit Reverses Last Year's Loss
Moderna Shares Jump 10% as Q3 Earnings Beat Forecasts and Revenue Outlook Improves
Moderna shares surge 10% on earnings beat and raised revenue outlook
Moderna Swings to 3Q Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes - Update | Morningstar
Moderna CEO Stephane Bancel on Q3 results: A big year of growth for us
Moderna Lifts Outlook, Swings to 3Q Profit | Morningstar
Moderna's stock jumps after biotech raises sales outlook | Morningstar
Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas
Moderna (MRNA) earnings Q3 2026
Moderna Q3 2026: First Profit in Years on a $1.31B Revenue Beat
Nasdaq futures make a small comeback after the tech wreck sends it into correction territory
Invesco S&P 500 Equal Weight (RSP) Adds Okta and Moderna on Nov. 4
Moderna Q3 26 Earnings Conference Call AT 8:00 AM ET
While biotech bets swing on trial data, this dividend payer gained 72% since 2024
Best Biotech Stocks To Watch Today - November 6th - Daily Political
6,541 Shares of Moderna, Inc. $MRNA Purchased by Caldwell Trust Co
October jobs report and earnings from Moderna and Humana: What to Watch
Moderna News | Markets Insider
Moderna (NASDAQ:MRNA) Stock Jumps 3.4% - Time to Buy? - Stock Observer
Moderna (NASDAQ:MRNA) Shares Down 6.5% - Here's Why
Ahead of Moderna Earnings, Here's What Barchart Data Says Comes Next for MRNA Stock
Promising Biotech Stocks To Watch Now - November 5th - Markets Daily
Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch
Healthcare Stocks To Keep An Eye On - November 5th - Daily Political
Moderna (MRNA) After WHO Vaccine Backing Looks Pricey Despite The Rally
Moderna (NASDAQ:MRNA) Shares Climb 13.1% - Here's Why
Which Dates Could Move Moderna Stock Most?
Moderna (NASDAQ:MRNA) Shares Climb 13.1% - Still a Buy? - Stock Observer
Biotech Stocks To Keep An Eye On - November 4th - Markets Daily
Moderna (NASDAQ:MRNA) Reaches New 1-Year High - Here's What Happened - Daily Political
Promising Healthcare Stocks To Consider - November 4th - Stock Observer
4,553 Shares of Moderna, Inc. $MRNA Purchased by Choreo LLC
Moderna (NASDAQ:MRNA) Shares Up 3.4% - Should You Buy?
Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
120,480 Shares in Moderna, Inc. $MRNA Purchased by Mirae Asset Global Investments Co. Ltd. - Markets Daily
What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Oct. 30
Could Investing in Moderna's Stock Double Your Money? - AOL
Promising Healthcare Stocks Worth Watching - November 3rd - Daily Political
Best Biotech Stocks To Follow Today - November 3rd - Daily Political
Moderna, Inc. $MRNA Shares Newly Purchased by BOCHK Asset Management Ltd
Moderna, Inc. $MRNA Stock Sold by Bank Julius Baer & Co. Ltd Zurich
Dolly Parton's $1 Million Donation Helped Fund Early Research Behind Moderna's COVID-19 Vaccine
John Dorfman: SanDisk, Micron, Marathon among high flyers
Analyzing Insmed (NASDAQ:INSM) and Moderna (NASDAQ:MRNA) - Markets Daily
Moderna News
Micron Stock Price Forecast 2026–2030: Can AI Memory Demand Reverse a 26% Week-to-Date Sell-Off?
Arm Holdings Stock Forecast 2026–2030: Can Data-Center Royalty Growth Drive a Recovery?
Moderna Shares Fall 18% After Cancer Vaccine Data Leak Triggers Sell-Off
Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks
Moderna Stock Rebounds 4.81% as Cancer Vaccine Focus Builds Ahead of Nasdaq-100 Return
Latest news
Show more
Gold Price Today: XAU/USD Slips Near $4,130 Ahead of US Inflation Data
Nvidia Stock Falls 4.3% as Board Opens Investigation Into CEO Jensen Huang
Anthropic Launches Claude Fable 5.2 and Mythos 5.2 as IPO Scrutiny Intensifies
Gold Price Today: XAU/USD Rises Above $4,100 Ahead of US Inflation Data
Nvidia Board Opens Huang Investigation as AI Financing Risks Draw Scrutiny
